First-line ipilimumab^a

Completed all 4 cycles of first-line therapy

82 (55.8)

Number of doses per patient, median (range)^b,c

4 (1 - 8)

Experienced ≥1 dose interruption, n (%)^b

54 (38.0)

Received at least 4 doses, n (%)^d

92 (64.8)

Supportive therapy^e,f

Steroids

55 (36.0)

Antidiarrheal

25 (16.3)

Infliximab

2 (1.3)

Radiotherapy^e,f

107 (69.9)

Hospice care^e,f

67 (43.8)